Enterprise HL7 / FHIR Terminology Engine
Universal Clinical Codes & Terminology Search
Search, verify, and inspect standardized LOINC, SNOMED CT, ICD-10-CM, RxNorm, and CPT clinical codes with native HL7 FHIR R4 resource mappings.
Showing 20 of 80174 codes
Per page:
Need to map or validate codes in bulk?
Cross-reference up to 1,000 ICD-10, LOINC, and CPT records simultaneously in memory with our free utility.
| Code Value | Display Description | Code System & OID | FHIR Resource | Category | Status | Actions |
|---|---|---|---|---|---|---|
|
XW023T6
|
Introduction of COVID-19 Vaccine Dose 2 into Muscle Percutaneous Approach New Technology Group 6
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW023U6
|
Introduction of COVID-19 Vaccine into Muscle Percutaneous Approach New Technology Group 6
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW023V7
|
Introduction of COVID-19 Vaccine Dose 3 into Muscle Percutaneous Approach New Technology Group 7
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW023W7
|
Introduction of COVID-19 Vaccine Booster into Muscle Percutaneous Approach New Technology Group 7
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW023Y7
|
Introduction of Other New Technology Monoclonal Antibody into Muscle Percutaneous Approach New Technology Group 7
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW03308
|
Introduction of Spesolimab Monoclonal Antibody into Peripheral Vein Percutaneous Approach New Technology Group 8
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW0330B
|
Introduction of Alpha1-proteinase Inhibitor into Peripheral Vein Percutaneous Approach New Technology Group 11
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW0331B
|
Introduction of Anitocabtagene Autoleucel Immunotherapy into Peripheral Vein Percutaneous Approach New Technology Group 11
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW0333A
|
Introduction of Bentracimab Ticagrelor Reversal Agent into Peripheral Vein Percutaneous Approach New Technology Group 10
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW0334A
|
Introduction of Cefepime-taniborbactam Anti-infective into Peripheral Vein Percutaneous Approach New Technology Group 10
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW03357
|
Introduction of Narsoplimab Monoclonal Antibody into Peripheral Vein Percutaneous Approach New Technology Group 7
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW03358
|
Introduction of Mosunetuzumab Antineoplastic into Peripheral Vein Percutaneous Approach New Technology Group 8
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW0335A
|
Introduction of Ceftobiprole Medocaril Anti-infective into Peripheral Vein Percutaneous Approach New Technology Group 10
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW03368
|
Introduction of Afamitresgene Autoleucel Immunotherapy into Peripheral Vein Percutaneous Approach New Technology Group 8
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW0336C
|
Introduction of Landiolol Antiarrhythmic into Peripheral Vein Percutaneous Approach New Technology Group 12
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW03372
|
Introduction of Inactivated Coagulation Factor Xa into Peripheral Vein Percutaneous Approach New Technology Group 2
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW03378
|
Introduction of Tabelecleucel Immunotherapy into Peripheral Vein Percutaneous Approach New Technology Group 8
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW0337C
|
Introduction of Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy into Peripheral Vein Percutaneous Approach New Technology Group 12
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW03388
|
Introduction of Treosulfan into Peripheral Vein Percutaneous Approach New Technology Group 8
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW0338A
|
Introduction of Obecabtagene Autoleucel into Peripheral Vein Percutaneous Approach New Technology Group 10
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
Healthcare Terminology & FHIR R4 Interoperability
Standardized coding guidelines governed by CodesForMD
In HL7 FHIR R4, discrete clinical findings and laboratory measurements are encapsulated inside
Observation resources. Diagnostic terms and problem list entries are represented within Condition resources, while surgical and therapeutic acts map to Procedure. CodesForMD adheres to official US Core and International FHIR Implementation Guides.
An OID is an internationally standardized dotted-decimal identifier (e.g.
2.16.840.1.113883.6.1 for LOINC) registered with HL7 and ISO. OIDs ensure unambiguous identification of terminology authorities when exchanging clinical messages across heterogeneous EHR, LIS, and PACS systems.
Yes. You can visit our platform's administrative ingestion and export engine or contact our team to obtain batch files of standardized codes.